SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Local drugmaker Otonomy Inc. is planning to ask the U.S. Food and Drug Administration for approval to sell its drug Otiprio for use in treating swimmer’s ear.January 12, 2017 4:14 p.m. $$ Share
Laura Farmer Sherman, president and CEO of Susan G. Komen San Diego, plans to retire at the end of 2017, the organization announced Tuesday.
A prostate cancer treatment center recently opened in La Jolla offering what it touts as a new image-guided treatment with few side effects and a quick recovery time.
Scripps Health is working to widen access to an HMO that now serves only its employees.
Shares of locally-based DexCom Inc. skyrocketed 26 percent January 13 following news that patients will have easier access to the medical device maker’s lead product.
Local biotech Access Biologics has sold a minority stake of the company for $51 million to Barcelona-based pharmaceutical and chemical firm, Grifols.
San Diego biotech AnaptysBio has hired a chief financial officer and signaled to the U.S. Securities and Exchange Commission that it plans to go public.
The University of California, San Diego will receive $10.5 million from Switzerland’s Family Larsson-Rosenquist Foundation to research the mysteries of human breast milk.
MEDICINE: Co. Guides Patient, Family Through Last Journey
Dr. Bob Uslander was meditating on a bluff in La Jolla in early 2013 when he was jolted by an epiphany that would transform his professional life.
During 2016, San Diego saw 103 venture capital investments for a total of about $1.28 billion, according to a MoneyTree report released this week by PwC and CB Insights.
San Diego medical device maker DexCom Inc. has reported $570 million in revenue for its fiscal 2016, a 42 percent jump over 2015.
The Scripps Research Institute has landed a deal with global drugmaker Pfizer Inc. in which Pfizer will use TSRI’s technology to find promising chemical leads for new drugs.
A plan by the Teamsters union to conduct a one-day labor strike Jan. 10 by clerical workers across the University of California system has been met with recrimination by UC San Diego Health, which said it plans to keep its facilities open during what it called a potentially illegal job action.
San Diego-based Mirati Therapeutics Inc. said Jan. 6 that it priced its initial public offering at $5.60 per share, raising up to $65 million before underwriting and related expenses. The offering is expected to close Jan. 11.
Sharp Chula Vista Medical Center’s chief medical officer has been appointed to a board that helps a number of state and regional groups improve industry performance and foster innovation.